mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |